To view this email as a web page, click here.

 
Why remove an IOL? Survey brings key trends into focus
Accurate IOL measurements, proper patient selection, and solid surgical techniques can help to reduce the number of IOL explantations.
See the results
ADVERTISEMENT
 
(PODCAST) Why IPL therapy is ideal for treating chalazion
image description here In our latest episode, Laura M. Periman, MD, shares her experience using intense pulsed light (IPL) therapy, and the benefits she's found in it for treating patients with chalazion.

Listen here!
 
ASRS 2019 Street Team recap: Chuck Hess
image description here Chuck Hess, vice president and general manager of the U.S. Surgical Division at Bausch + Lomb, shares what's in the surgical pipeline at Bausch + Lomb at the 2019 annual American Society of Retina Specialists meeting in Chicago.

Watch here
 
RELATED ARTICLES
 
Impact of MGD treatment on keratometry
ASRS 2019 Street Team recap: Rishi P. Singh, MD
Greater IOP-lowering potential with iStent inject
Alcon debuts AcrySof IQ PanOptix trifocal IOL to U.S. market
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.